New oral antiviral drug to be used for treatment of COVID-19
Share - WeChat

The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- Sculpture for Flying Tigers is unveiled in Chongqing
- China's V-Day gathering to start at 9 am, Sept 3 at Tian'anmen Square
- Fuzhou determined to become an 'international, people-oriented' city
- Experts highlight health risks of modern lifestyle habits
- China's first science popularization month kicks off in Beijing
- Fudan University welcomes freshmen with academician, robot